Atherotech Diagnostics Lab Release: Lipid Remnants Measured by VAP® Lipid Panel Associated With 28% Increase in Heart Attack Events in Jackson Heart Study Population
3/11/2013 11:12:26 AM
SAN FRANCISCO--(BUSINESS WIRE)--Researchers investigating heart disease in African Americans presented findings today showing that increased levels of remnant lipoprotein cholesterol measured with Atherotech Diagnostics Lab’s VAP® Lipid Panel were a significant, independent predictor of heart attack events among study participants. Oral abstract #919-6 Triglyceride-Rich Remnant Lipoprotein Cholesterol Predicts Acute Myocardial Infarction in African Americans: The Jackson Heart Study was presented by study lead author Arif A. Khokhar, B.M., B.Ch., M.A. (CANTAB), at the American College of Cardiology’s Annual Scientific Session (ACC.13). Study results demonstrated that in multivariable analysis a one standard deviation increase in triglyceride-rich remnant lipoprotein cholesterol (RLPc) was associated with a 28-percent increased heart attack risk among African Americans. The Jackson Heart Study represents the largest investigation to date of causes of cardiovascular disease in an African American population.